Following a national consultation exercise the objectives of post were stated in implementation guidance: "To help provide better outcomes for patients by improving services and quality, "To strengthen leadership, "To provide a new career opportunity to help retain experienced and expert nurses, midwives and health visitors in practice".
8– 10 The objective of this post hoc analysis was to evaluate the variability in pancreatic enzyme concentrations in type 2 diabetic and obese nondiabetic (control) populations.
The primary objective of these post hoc analyses was to examine the potential relationship between different olanzapine LAI doses and changes in safety and efficacy parameters.
The objective of this post hoc analysis was to examine the efficacy and safety of ULT with febuxostat or allopurinol in a subset of elderly subjects enrolled in the CONFIRMS trial.
The objective of this post hoc analysis was to evaluate the efficacy and safety of pregabalin in older patients with neuropathic pain using pooled double-blind, randomized, placebo-controlled studies of pregabalin in patients with DPN or PHN.
The objective of this post hoc analysis was to examine the efficacy and safety profile of LDX by sex and age group in children with ADHD in a laboratory school setting.
The objective of this post hoc analysis was to assess the influence of seasonality on bleeding frequency and patient-assessed pain in these patients with haemophilia B receiving on-demand therapy.
The objective of this post hoc subgroup analysis described herein was to identify a "better efficacy" patient population within VELOUR study that may have derived greater clinical benefit from treatment with FOLFIRI plus aflibercept.
The objective of this post hoc subgroup analysis was to evaluate the effects of IPE on lipids, lipoproteins, and inflammatory biomarkers in the patients with diabetes mellitus from the ANCHOR study, with subanalysis by degree of glycemic control (glycosylated hemoglobin A1c [aboveabore or below the median).
The objective of this post hoc subanalysis of the CONFIRMS trial [ 23], the largest ULT RCT to date, was to examine the urate-lowering efficacy and safety of febuxostat and allopurinol in hyperuricemic African American subjects with gout in comparison to Caucasian subjects.
